help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casanueva, F. F.
Right arrow Articles by Fernandez-Cruz, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casanueva, F. F.
Right arrow Articles by Fernandez-Cruz, A.

Journal of Clinical Endocrinology & Metabolism, Vol 59, 526-530, Copyright © 1984 by Endocrine Society


ARTICLES

Cholinergic mediation of growth hormone secretion elicited by arginine, clonidine, and physical exercise in man

FF Casanueva, L Villanueva, JA Cabranes, J Cabezas-Cerrato and A Fernandez-Cruz

The role of acetylcholine in human GH secretion was studied with atropine, which selectively blocks cholinergic muscarinic receptors and crosses the blood-brain barrier. Paired tests were performed in 22 normal subjects divided into 4 groups. The stimuli employed were arginine (30 g/30 min, iv), clonidine (300 micrograms, orally), physical exercise for 20 min, and saline. In the second test, atropine (1 mg, im) was administered before GH stimulation. Arginine elicited a GH secretory peak of 16.6 +/- 5 ng/ml (mean +/- SEM), which was completely blocked when atropine was administered with arginine (0.9 +/- 0.1 ng/ml). Atropine did not, however, modify the PRL secretory response; peak levels after arginine and atropine plus arginine were 16.3 +/- 3.1 and 16.8 +/- 2.5 ng/ml, respectively. Clonidine elicited a GH secretory peak (11.8 +/- 2.7 ng/ml) which also was blocked by pretreatment with atropine (1.2 +/- 0.2 ng/ml). Neither clonidine nor clonidine plus atropine altered PRL secretion. GH levels also were sharply increased after physical exercise, with a peak level of 19.4 +/- 4.9 ng/ml. Atropine completely blocked exercise-induced GH secretion (2 +/- 0.9 ng/ml). Atropine alone did not modify GH or PRL values compared with saline administration. The potency of the atropine-induced suppression of GH secretion by three different stimuli, each with presumably different mechanisms of action, suggests that acetylcholine plays an important role in the regulation of GH secretion.


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
S. R. Collier, E. Collins, and J. A. Kanaley
Oral arginine attenuates the growth hormone response to resistance exercise
J Appl Physiol, September 1, 2006; 101(3): 848 - 852.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
W. R. de Vries, N. T. M. Bernards, M. H. de Rooij, and H. P. F. Koppeschaar
Dynamic Exercise Discloses Different Time-Related Responses in Stress Hormones
Psychosom Med, December 1, 2000; 62(6): 866 - 872.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Weltman, C. J. Pritzlaff, L. Wideman, J. Y. Weltman, J. L. Blumer, R. D. Abbott, M. L. Hartman, and J. D. Veldhuis
Exercise-dependent growth hormone release is linked to markers of heightened central adrenergic outflow
J Appl Physiol, August 1, 2000; 89(2): 629 - 635.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. Wideman, J. Y. Weltman, N. Shah, S. Story, J. D. Veldhuis, and A. Weltman
Effects of gender on exercise-induced growth hormone release
J Appl Physiol, September 1, 1999; 87(3): 1154 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. E. Muller, V. Locatelli, and D. Cocchi
Neuroendocrine Control of Growth Hormone Secretion
Physiol Rev, April 1, 1999; 79(2): 511 - 607.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Giustina and J. D. Veldhuis
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human
Endocr. Rev., December 1, 1998; 19(6): 717 - 797.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Matsunaga, M. Wakiya, S. G. Roh, M. Hirota, M. L. He, S. Hidaka, and H. Hidari
Effect of cholinergic blockade on inhibited GH secretion by feeding and intraruminal SCFA infusion in sheep
Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E45 - E51.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society